Asia Pacific Organoids Services Market Report (2021-2031) by Scope, Segmentation, Dynamics, and Competitive Analysis
Description
The Asia Pacific organoids services market is projected to grow significantly, reaching approximately US$ 2,327.10 million by 2031, up from US$ 515.83 million in 2024, reflecting a robust compound annual growth rate (CAGR) of 24.0% during the forecast period from 2024 to 2031.
Executive Summary and Market Analysis
The market is divided into several regions, including Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The rapid growth in this region is driven by several factors, including the increasing adoption of organoids, government initiatives to promote awareness of human organoids, supportive regulatory frameworks for the development and commercialization of advanced organoid products, and a rise in funding for organoid research.
Market Segmentation Analysis
The Asia Pacific organoids services market can be segmented by type, application, and source:
By Type: The market includes segments such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.
By Application: The applications are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is anticipated to hold the largest market share in 2024.
By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with the pluripotent stem cells segment expected to lead in market share in 2024.
Market Outlook
The healthcare sector's advancements have led to increased demand for organoids globally, fostering new product developments, acquisitions, partnerships, and product launches. Recent notable developments in the market include:
June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new IBD therapies.
July 2023: Molecular Devices expanded its custom organoid line service for high-throughput applications.
February 2023: A strategic collaboration between Molecular Devices and HUB Organoids aimed to advance 3D biology technologies to reduce drug attrition rates.
December 2022: Molecular Devices acquired Cellesce Ltd. to enhance PDO production capabilities for drug screening.
August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
February 2020: InnoSer and OrganoTherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.
These developments indicate a vibrant market landscape with numerous opportunities for growth in organoid services.
Country Insights
The Asia Pacific Organoids Services Market includes key countries such as Australia, China, India, Japan, South Korea, and others. China is expected to hold the largest market share in 2024, driven by the growing interest in personalized medicine, which fuels organoid research and development. Notable initiatives in China include a partnership between HUB and BGI-Qingdao to enhance personalized care and the introduction of a robot with a human brain organoid, showcasing advancements in organoid technology.
Company Profiles
Key players in the Asia Pacific organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.
Reasons to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids services market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific organoids services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific organoids services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Executive Summary and Market Analysis
The market is divided into several regions, including Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The rapid growth in this region is driven by several factors, including the increasing adoption of organoids, government initiatives to promote awareness of human organoids, supportive regulatory frameworks for the development and commercialization of advanced organoid products, and a rise in funding for organoid research.
Market Segmentation Analysis
The Asia Pacific organoids services market can be segmented by type, application, and source:
By Type: The market includes segments such as intestine, liver, stomach, pancreas, lung, brain, kidney, and others. In 2024, the intestine segment is expected to dominate the market share.
By Application: The applications are categorized into developmental biology disease, pathology of infectious disease, regenerative medicine, drug toxicity and efficacy testing, drug discovery and personalized medicine, among others. The developmental biology disease segment is anticipated to hold the largest market share in 2024.
By Source: The market is divided into pluripotent stem cells and organ-specific adult stem cells, with the pluripotent stem cells segment expected to lead in market share in 2024.
Market Outlook
The healthcare sector's advancements have led to increased demand for organoids globally, fostering new product developments, acquisitions, partnerships, and product launches. Recent notable developments in the market include:
June 2024: Molecular Devices, LLC opened a new facility in Cardiff, UK, designed for large-scale production of patient-derived organoids (PDOs) using innovative bioprocess technology.
May 2024: InSphero entered a partnership with Genome Biologics to commercialize a 3D Cardiac Organoid Platform, enhancing heart disease research capabilities.
January 2024: HUB Organoids launched IntegriGut Screen services, utilizing IBD patient-derived organoid monolayers to support the development of new IBD therapies.
July 2023: Molecular Devices expanded its custom organoid line service for high-throughput applications.
February 2023: A strategic collaboration between Molecular Devices and HUB Organoids aimed to advance 3D biology technologies to reduce drug attrition rates.
December 2022: Molecular Devices acquired Cellesce Ltd. to enhance PDO production capabilities for drug screening.
August 2021: STEMCELL Technologies partnered with HUB to provide tissue-derived organoids for preclinical testing.
May 2020: CELLINK collaborated with AstraZeneca to develop 3D bioprinted liver organoids for drug discovery.
February 2020: InnoSer and OrganoTherapeutics announced a collaboration to commercialize midbrain organoids for Parkinson's disease research.
These developments indicate a vibrant market landscape with numerous opportunities for growth in organoid services.
Country Insights
The Asia Pacific Organoids Services Market includes key countries such as Australia, China, India, Japan, South Korea, and others. China is expected to hold the largest market share in 2024, driven by the growing interest in personalized medicine, which fuels organoid research and development. Notable initiatives in China include a partnership between HUB and BGI-Qingdao to enhance personalized care and the introduction of a robot with a human brain organoid, showcasing advancements in organoid technology.
Company Profiles
Key players in the Asia Pacific organoids services market include CUSABIO TECHNOLOGY LLC, Cyprio, Eurofins Scientific SE, HUB Organoids B.V., InnoSer, InSphero, LABTOO, Molecular Devices, LLC, Oncodesign Services, and Sino Biological Inc. These companies are pursuing various strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.
Reasons to buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific organoids services market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific organoids services market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific organoids services market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
136 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
- 4. Asia Pacific Organoids Services Market Landscape
- 4.1 PEST Analysis
- 5. Asia Pacific Organoids Services Market - Key Market Dynamics
- 5.1 Asia Pacific Organoids Services Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increasing Demand for Innovative Drug Screening Services
- 5.2.2 Surge in Popularity of Personalized Drugs
- 5.3 Market Restraints
- 5.3.1 Dearth of Skilled Professionals
- 5.4 Market Opportunities
- 5.4.1 Increasing Key Developments
- 5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence
- 5.6 Impact of Drivers and Restraints:
- 6. Asia Pacific Organoids Services Market - Analysis
- 6.1 Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
- 6.2 Asia Pacific Organoids Services Market Forecast Analysis
- 7. Asia Pacific Organoids Services Market Analysis - by Type
- 7.1 Intestine
- 7.1.1 Overview
- 7.1.2 Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.2 Liver
- 7.2.1 Overview
- 7.2.2 Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.3 Stomach
- 7.3.1 Overview
- 7.3.2 Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.4 Pancreas
- 7.4.1 Overview
- 7.4.2 Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.5 Lung
- 7.5.1 Overview
- 7.5.2 Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.6 Brain
- 7.6.1 Overview
- 7.6.2 Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.7 Kidney
- 7.7.1 Overview
- 7.7.2 Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 7.8 Others
- 7.8.1 Overview
- 7.8.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8. Asia Pacific Organoids Services Market Analysis - by Application
- 8.1 Developmental Biology Disease
- 8.1.1 Overview
- 8.1.2 Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.2 Pathology of Infectious Disease
- 8.2.1 Overview
- 8.2.2 Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.3 Regenerative Medicine
- 8.3.1 Overview
- 8.3.2 Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.4 Drug Toxicity and Efficacy Testing
- 8.4.1 Overview
- 8.4.2 Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.5 Drug Discovery and Personalized Medicine
- 8.5.1 Overview
- 8.5.2 Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 8.6 Others
- 8.6.1 Overview
- 8.6.2 Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9. Asia Pacific Organoids Services Market Analysis - by Source
- 9.1 Pluripotent Stem Cells
- 9.1.1 Overview
- 9.1.2 Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 9.2 Organ Specific Adult Stem Cell
- 9.2.1 Overview
- 9.2.2 Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10. Asia Pacific Organoids Services Market - Country Analysis
- 10.1 Asia Pacific
- 10.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.1.1.1 Asia Pacific Organoids Services Market - Revenue and Forecast Analysis - by Country
- 10.1.1.2 Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.2.1 Japan: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.2.2 Japan: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.2.3 Japan: Asia Pacific Organoids Services Market Share - by Source
- 10.1.1.3 China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.3.1 China: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.3.2 China: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.3.3 China: Asia Pacific Organoids Services Market Share - by Source
- 10.1.1.4 India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.4.1 India: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.4.2 India: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.4.3 India: Asia Pacific Organoids Services Market Share - by Source
- 10.1.1.5 South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.5.1 South Korea: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.5.2 South Korea: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.5.3 South Korea: Asia Pacific Organoids Services Market Share - by Source
- 10.1.1.6 Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.6.1 Australia: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.6.2 Australia: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.6.3 Australia: Asia Pacific Organoids Services Market Share - by Source
- 10.1.1.7 Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- 10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Type
- 10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Application
- 10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Organoids Services Market Share - by Source
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Growth Strategies in Organoids Services Market
- 11.3 Organic Growth Strategies
- 11.3.1 Overview
- 11.4 Inorganic Growth Strategies
- 11.4.1 Overview
- 12. Company Profiles
- 12.1 Sino Biological Inc.
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Eurofins Scientific SE
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Molecular Devices, LLC.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 InSphero
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 Cyprio
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 InnoSer
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 LABTOO
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 CUSABIO TECHNOLOGY LLC
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Oncodesign Services
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 HUB Organoids B.V. (Hubrecht Organoid Technology)
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
- 13. Appendix
- 13.1 About The Insight Partners
- 13.2 Glossary of Terms
- List of Tables
- Table 1. Asia Pacific Organoids Services Market Segmentation
- Table 2. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Table 3. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Type
- Table 4. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
- Table 5. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Source
- Table 6. Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
- Table 7. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 8. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 9. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 10. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 11. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 12. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 13. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 14. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 15. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 16. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 17. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 18. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 19. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 20. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 21. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 22. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Type
- Table 23. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
- Table 24. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Source
- Table 25. Recent Organic Growth Strategies in Organoids Services Market
- Table 26. Recent Inorganic Growth Strategies in the Organoids Services Market
- Table 27. Glossary of Terms, Organoids Services Market
- LIST OF FIGURES
- Figure 1. Asia Pacific Organoids Services Market Segmentation - Country
- Figure 2. PEST Analysis
- Figure 3. Impact Analysis of Drivers and Restraints
- Figure 4. Asia Pacific Organoids Services Market Revenue (US$ Million), 2021-2031
- Figure 5. Asia Pacific Organoids Services Market Share (%) - by Type (2023 and 2031)
- Figure 6. Intestine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 7. Liver: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 8. Stomach: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 9. Pancreas: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 10. Lung: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 11. Brain: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 12. Kidney: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 13. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 14. Asia Pacific Organoids Services Market Share (%) - by Application (2023 and 2031)
- Figure 15. Developmental Biology Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 16. Pathology of Infectious Disease: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 17. Regenerative Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 18. Drug Toxicity and Efficacy Testing: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 19. Drug Discovery and Personalized Medicine: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 20. Others: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 21. Asia Pacific Organoids Services Market Share (%) - by Source (2023 and 2031)
- Figure 22. Pluripotent Stem Cells: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 23. Organ Specific Adult Stem Cell: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
- Figure 24. Asia Pacific Organoids Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
- Figure 25. Japan: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 26. China: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 27. India: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 28. South Korea: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 29. Australia: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 30. Rest of Asia Pacific: Asia Pacific Organoids Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
- Figure 31. Growth Strategies in Organoids Services Market
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.